Vericel Corporation (VCEL) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Public company logo of vcel.com (VCEL)

Vericel Corporation management controls the production of cellular products at its plants, delegating delivery to express couriers. The GURU.Markets service reports the company's current EV/EBITDA multiple, which stands at 73.37. This reflects its leadership in cartilage and burn therapies with high FCF, as well as the use of climate control during the transport of living tissues to ensure surgical success.

Vericel Corp. - VCEL Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/12/2026)

vcel.com (VCEL) - metric breakdowns and financial figures

- market price and analyst price targets:
Price Chart Vericel Corp.|VCEL - Analyst Median Target
- market capitalization details:
Market Value Vericel Inc.|VCEL - Enterprise Value
- book value of equity indicators:
Book Value per Share Vericel|VCEL - Book Valuation of Business|Market Value to Book Value Ratio vcel.com|VCEL - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Vericel Corporation|VCEL - Long-Term Debt to Equity|Short-Term Debt to Capital Vericel|VCEL - Company Cumulative Debt|Debt to Book Capitalization Ratio Vericel Inc.|VCEL - Company Long-Term Loans and Borrowings|Company Short-Term Debts Vericel|Quick Ratio vcel.com
- financial results and valuation multiples details:
VCEL - Net Income|Projected Future Earnings Vericel Corporation|VCEL - Market Cap to Earnings|Future Price to Earnings Vericel Corporation|VCEL - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Vericel Inc.|VCEL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Vericel|VCEL - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months vcel.com|VCEL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Vericel Corporation
Initial company analysis:VCEL (Vericel Corp.)
Manufactured products of vcel.com

High-margin sales of MACI and Epicel cell therapies form the operational base of Vericel Corporation (VCEL), determining its fundamental value. This indicator correlates the enterprise value (EV) with earnings before interest, taxes, depreciation, and amortization (EBITDA), allowing for an assessment of the real value of assets without distortions from debt load, which makes the EV/EBITDA chart a key tool for identifying trend reversal points.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Krystal Corp KRYS|Total Company Value to Operating Income Before Depreciation Ratio Apogee Corp (APGE)|ARQT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ORKA - EV/EBITDA Multiple|SMTI: EV/EBITDA Multiple|DBVT - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Solesence Beauty|Enterprise Value to Operating Income Before Depreciation DERM (Journey Medical Corp.)|Enterprise Value to EBITDA Ratio FBRX (Forte Biosciences, Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization EMPG (empro.my)|EV/EBITDA Multiple SLGL (Sol-Gel Technologies Ltd.)|AXIL Brands Inc (AXIL) - Company Value to EBITDA|MDCX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation VRCA (Verrica Pharmaceuticals)|HOTH: EV/EBITDA Multiple|BFRI - Total Company Value to Operating Income Before Depreciation Ratio|VYNE (VYNE Therapeutics, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Sonoma Pharma (SNOA)|EV/EBITDA Multiple QNRX|AZTR - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dermata Therapeutics DRMA|elevaiskincare.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RVNC: Enterprise Value to EBITDA Ratio